20210726 date as of change: 20210726 subject company: company data: company conformed name: celularity inc central index key: 0001752828 standard industrial . Brooke Knowlton. careers@cellarity.com. Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases. Celularity Inc. is a clinical-stage biotechnology company engaged in developing off-the-shelf placental-derived allogenic cell therapy product candidates. Jennifer Burk's HQ phone number is (908) 768-2170 Which industry does Jennifer Burk work in? In Jan. 2021, Celularity and GXGX (GX Acquisition) announced a . Administrative Assistant to the President at CELULARITY FUNCTIONAL REGENERATION, LLC. CELU is lower by -$3.16 from the previous closing price of $10.84 on volume of 878,731 shares. and the conversion into the right to receive a number of shares of Class . Celularity employs 0 staff and has a market cap (total outstanding stock value) of $201.6 million. 101 South Street 6th Floor Somerville, MA 02143. Work Experience Education Skills Radar Brain Sign Current Company FAQs About Yvonne Milonopoulos's Work Experience . Celularitythe application to list its biotech unit on the STAR market. Check Celularity financial statements over time to gain insight into future company performance. This website uses cookies to ensure you get the best experience on our website. Yes No. PROSPECTUS SUPPLEMENT No. The number of followers has increased 0.8% month over month and increased 4% quarter over quarter. Company profile page for Celularity Operations Inc including stock price, company news, press releases, executives, board members, and contact information Celularity Inc. is a clinical-stage biotechnology company engaged in developing off-the-shelf placental-derived allogenic cell therapy product candidates. (Sales figure is modelled). Celularity's official website is www.celularity.com . It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. (201) ***-*271 Phone number View Bradford Bell's Email & Phone Number Wrong Bradford Bell? Celularity, Inc. specialises in biotechnology. CELUW | Complete Celularity Inc. Wt stock news by MarketWatch. Celularity 's Trends. Celularity's origins. Contact Us; GX Acquisition Corp. (Celularity) . 333-258600 A higher number is better than a lower number. Products Web Platform Chrome Plugin API. The price range a stock has traded at during the most recent trading period.-- There are 5 companies in . 2020. Phone Number 908-768-2170. Celularity, Inc. overview Celularity, Inc. top contacts Similar Companies to Celularity, Inc. Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell . . View the latest Celularity Inc. (CELU) stock price, news, historical charts, analyst ratings and financial information from WSJ. florham park, n.j., march 15, 2022 (globe newswire) -- celularity inc. (nasdaq: celu) ("celularity"), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic. Headline. The company or organization that Kyle Harold Fletcher serves is Celularity, Inc.. Celularity, Inc. Business Profile Celularity, Inc. Cord Blood Banking Contact Information 170 Park Ave Florham Park, NJ 07932-1049 http://www.lifebankusa.com Email this Business (844) 963-2273 Want. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. Map view. and involve a number of judgments, risks and . Work Experience Education Skills Radar Brain Sign Current Company FAQs About Bradford Bell's Work Experience . Celularity Media Contact: Jason Braco, Ph.D. LifeSci Communications jbraco@lifescicomms.com. The company currently specializes in the Biotechnology, Biotechnology areas. Celularity's intellectual property and research portfolio consists of 800 patents as well as pre-clinical and clinical assets, including CAR constructs for allogeneic CAR-T/NK products, licenses to 100+ immunotherapy assets, and commercial stage biosourcing and functional regeneration businesses. Find company research, competitor information, contact details & financial data for Celularity LLC of Florham Park, NJ. Solutions Sales Marketing. Its last market close was $10.18 - an increase of 0.3% over the previous week. View Courtnay Pappalardo's business profile as Human Resources Specialist at Celularity Inc.. Find Courtnay's email address, mobile number, work history, and more. Nathaniel is based out of North Brunswick, New Jersey, United States and works in the Biotechnology industry. The phone number is (908) 845-4366. Celularity's headquarters are in 170 Park Avenue, Florham Park, New Jersey, 07932, United States What is Celularity's phone number? GX Contact Caroline Luz . Celularity (NASDAQ:CELU) Shares Gap Up to $3.78. 2019. . News. Celularity Warren NJ, 07059 - Manta.com U.S. Warren, NJ Professional Services Commercial Physical and Biological Research Commercial Medical Research Celularity UNCLAIMED 7 Powderhorn Drive Warren, NJ 07059 (732) 469-0478 Visit Website About Contact Details Reviews Claim This Listing About Categorized under Commercial Medical Research. Stem cell start-up that raised $250 million could extend lifespan by decades, help cure cancer. The company's lead therapeutic programs include CYCART-19, a placental . Select a tab. Phone Number. Courtnay Pappalardo's HQ phone number is +1 908-673-9000. It operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. . Fact checked. See insights on Celularity including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The position of the Chairman & CEO is occupied by Robert Hariri. Celularity Inc. is a clinical-stage biotechnology company engaged in developing off-the-shelf placental-derived allogenic cell therapy product candidates. Jennifer Burk's business email address is j***@celularity.com What is Jennifer Burk's direct phone number? Celularity Incorporated: ClinicalTrials.gov Identifier: NCT04365101 Other Study ID Numbers: CYNK-001-COVID-19 : First Posted: April 28, 2020 Key Record Dates: Last Update Posted: May 25, 2022 Last Verified: May 2022 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Reach out directly with real-time validated email and phone numbers, and take it to the next step by creating personal and reusable email templates that integrate with your existing email provider. Click map to enlarge. . Hariri founded Celularity in 2016, although the idea behind the company first formed around 30 years ago, when he was a young surgeon at Cornell Medical Center in New York. June 8, 2022 - We have updated our scoring model to include (Float - Short Interest) as a ranking factor. The stock had previously closed at $3.61, but opened at $3.74. Celularity is a shell companies business based in the US. Sales per Business: 2020: 2021: Delta: Degenerative . Clinical Scale. Including laboratory and advanced manufacturing space for cellular medicine & biomaterials. Additional Information and Where to Find It. celularity, inc. (nasdaq: celu) headquartered in florham park, n.j., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (nk) cells, genetically-modified nk cells, t-cells engineered with a car (car 225. Number Of Employees 225 Sector Commercial Services. Celularity (CELU) Is a Risky but Attractive Play After the GXGX Merger. 150,000 Square Feet. The office address is 33 Technology Dr, Warren, NJ 07059-5148, United States of America. The USPTO has given the CELULARITY IMPACT trademark a serial number of 97265928. The number ranges from 0 to 100, with higher numbers indicating a higher risk of a short squeeze relative to its peers, and 50 being the average. . 20210726 20210726171950 accession number: 0001213900-21-038713 conformed submission type . Bob Hariri at Celularity's Warren, N.J., headquarters. David Beers Chief Financial Officer Executive Finance , Management Dec Dec Dec. Celularity Annual Number of Employees. Dec Dec Dec Annual Growth Rate. 2018. Celularity has 280 employees across 3 locations and $290 m in total funding,. and involve a number of judgments, risks and uncertainties. Number of employees: 225 people. a) each share of Legacy Celularity Common Stock (including shares of Legacy Celularity Common Stock resulting from the conversion of shares of Celularity Preferred Stock described above) that was issued and outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive a number of shares of Company Class A common stock, par value $0.0001 per share . The company's File Number is listed as 001384752. That deal provided Celularity with $138m of cash, including an $83m Pipe financing, but took five months to close owing to a large number of redemptions, and GX having to vote to extend its life. Celularity Inc. Medical laboratory. Source. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. Company profile page for Celularity Operations Inc including stock price, company news, press releases, executives, board members, and contact information It's a small number. Do not enter personal information (eg. To Top. Its headquarters is located at New Jersey, New Jersey, USA. Associate Manager, Desktop Support at Celularity, Inc. Hackettstown, New Jersey. You'd think that upon regulatory approvals, a revolution like this would become . . Celularity's stock symbol is CELU What is Celularity's official website? Contact Us Address. americanbankingnews.com - June 24 at 4:50 AM. These risks . Number of employees: 225 people. The law school graduated is Seton Hall University School . . May 18, 2022 Celularity Inc. (Nasdaq: CELU) ("Celularity"), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor . It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. 9 Grade C/ISO-7 suites &. Deferred Compensation Award (Limited Exercisability) Celularity Inc. (the "Company"), under its 2017 Equity Incentive Plan (the "Plan"), hereby grants to Awardholder a limited-exercisability Award (the "Award") to purchase the number of shares of the Company's Common Stock set forth below.The Award is subject to all of the terms and conditions as . clicks and the number of times the company . A number of other research firms have also weighed in on CELU. CYNK-001 is an allogeneic off the shelf cell therapy enriched for CD56+/CD3- NK cells expanded from human . Celularity shares last traded at $3.81 . All GMP-CAPABLE. no more than an estimated 1,000 to 2,000 patients have received CAR-T therapy. NASDAQ CELU Select a tab. "I give my oldest daughter credit, because when she was in utero, I went to look at the ultrasound of my first child," he recalls. What is Celularity's ISIN number? In this proxy statement, the terms "Celularity," "we," "us," and "our" refer to Celularity Inc. On July 16, 2021, or the Closing Date, we consummated the previously announced merger pursuant to that certain . (201) ***-*277 Phone number View Yvonne Milonopoulos's Email & Phone Number Wrong Yvonne Milonopoulos? Celularity Investor Contacts: Carlos Ramirez Celularity carlos.ramirez@celularity.com. ET by Tomi Kilgore Celularity started at outperform with $9 stock price target at Oppenheimer CELU lost -$3.06 per share the over the last 12 months. Celularity Inc (CELU) stock has fallen -29.15% while the S&P 500 is higher by 0.59% as of 2:22 PM on Monday, Jun 6. Alexandra Roy Solebury Trout aroy@troutgroup.com Celularity Media Contact: Jason Braco, Ph.D. LifeSci . On Monday, February 14, 2022, a trademark application was filed for CELULARITY IMPACT with the United States Patent and Trademark Office. 14 2021, Published 10:16 a.m. Currently working as Chief Financial Officer at Celularity in Michigan, United States. It operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Day Range i. Jul. Organize your contacts with fully customizable lists and integrate with your existing CRM or ATS for seamless workflow. 9 : Filed Pursuant to Rule 424(b)(3) (to Prospectus dated August 12, 2021) Registration No. Work Experience Education Skills Radar Brain Sign Current Company FAQs About Bradford Bell's Work Experience . Stock analysis for Celularity Inc (CELU) including key statistics, news & analysis to help you make more informed investment decisions. Over the past year the S&P 500 has fallen -2.22% while CELU is lower by -24.48%. Connect with intelligence. . It operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Product About Create Free Account. . A new biotech start-up Celularity is mining the . Celularity General Information. The board of directors of Celularity Inc. is using this proxy statement to solicit proxies for use at the Annual Meeting. 6 Grade D/ISO-8 labs. @celularity.com @celgene.com @lifebankusa.com @gmail.com @humanlongevity.com +3 more Robert Hariri Phone Number Found 6 phone numbers: 908-285-XXXX 908673XXXX 908-673-XXXX 877-543-XXXX 908-696-XXXX View Robert's Email & Phone (It's Free) No credit card required.